TipRanks
Go Ultimate55% OFF

CytoMed Therapeutics Limited (GDTC) Ownership - Who Owns CytoMed Therapeutics Limited?

CytoMed Therapeutics Limited (GDTC) Ownership Overview

  • 14.66% Insiders
  • 0.04% Mutual Funds
  • 0.19% Other Institutional Investors
  • 85.11% Public Companies and Individual Investors

The ownership structure of CytoMed Therapeutics Limited (GDTC) stock is a mix of institutional, retail, and individual investors. Approximately 0.23% of the company’s stock is owned by Institutional Investors, 14.66% is owned by Insiders, and 85.11% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Jul 23, 2026Chee Kong Choo$300,000
Jun 14, 2026Chee Kong Choo$127,680
May 13, 2026Rule 144, Affiliate$98,094
Feb 12, 2026Rule 144, Affiliate$122,030

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

GDTC top shareholders
Holder# of SharesType% HoldingValue
Rule 144, Affiliate1,104,186Insider9.33%1,013,643
Chee Kong Choo630,324Insider5.33%578,637
Fidelity Concord Street Trust4,854Institution0.04%4,456

Top Mutual Fund Holders

GDTC top mutual fund holders
Holder# of SharesType% HoldingValue
Fidelity Concord Street Trust4,854Institution0.04%4,456

FAQ

Who Owns CytoMed Therapeutics Limited (GDTC)?
According to the latest TipRanks data, approximately 0.19% of the company's stock is held by institutional investors, 14.66% is held by insiders, and 85.11% is held by retail investors.
What percentage of CytoMed Therapeutics Limited (GDTC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.19% of CytoMed Therapeutics Limited (GDTC) stock is held by institutional investors.
What percentage of CytoMed Therapeutics Limited (GDTC) stock is held by retail investors?
According to the latest TipRanks data, approximately 85.11% of CytoMed Therapeutics Limited (GDTC) stock is held by retail investors.
Who owns the most shares of CytoMed Therapeutics Limited (GDTC)?
Rule 144, Affiliate owns the most shares of CytoMed Therapeutics Limited (GDTC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.